Form 8-K - Current report:
SEC Accession No. 0001493152-24-050203
Filing Date
2024-12-16
Accepted
2024-12-16 16:00:16
Documents
22
Period of Report
2024-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61962
2 ex1-01.htm EX-1.01 275056
3 ex4-01.htm EX-4.01 129236
4 ex4-02.htm EX-4.02 130531
5 ex4-03.htm EX-4.03 149016
6 ex10-01.htm EX-10.01 14816
7 ex99-01.htm EX-99.01 16845
8 ex99-02.htm EX-99.02 16594
9 ex99-01_001.jpg GRAPHIC 18467
10 ex99-02_001.jpg GRAPHIC 18393
  Complete submission text file 0001493152-24-050203.txt   1180375

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE pali-20241216.xsd EX-101.SCH 3024
12 XBRL LABEL FILE pali-20241216_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE pali-20241216_pre.xml EX-101.PRE 24171
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3691
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 241551731
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)